SEC Form 4 · accession 0001534424-19-000064
ClearPoint Neuro, Inc. · CLPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Michael Burnett
Officer — CEO and President · Director
Period of report
Feb 7, 2019
Accepted (ET)
Feb 11, 2019 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001285550
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 7, 2019 | F | 6,475 | $2.75 | D | 261,538 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.